FI951961A0 - Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita - Google Patents

Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita

Info

Publication number
FI951961A0
FI951961A0 FI951961A FI951961A FI951961A0 FI 951961 A0 FI951961 A0 FI 951961A0 FI 951961 A FI951961 A FI 951961A FI 951961 A FI951961 A FI 951961A FI 951961 A0 FI951961 A0 FI 951961A0
Authority
FI
Finland
Prior art keywords
preparation
pct
dihydrogen orthophosphate
pharmaceutical preparations
preparations containing
Prior art date
Application number
FI951961A
Other languages
English (en)
Swedish (sv)
Other versions
FI113642B (fi
FI951961A (fi
Inventor
Wolfgang Herrmann
Armin Knapp
Hans Klausmann
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of FI951961A publication Critical patent/FI951961A/fi
Publication of FI951961A0 publication Critical patent/FI951961A0/fi
Application granted granted Critical
Publication of FI113642B publication Critical patent/FI113642B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
FI951961A 1992-10-26 1995-04-25 Menetelmä tilidiinidivetyortofosfaatin valmistamiseksi FI113642B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4236074 1992-10-26
DE4236074 1992-10-26
PCT/EP1993/002954 WO1994010129A1 (de) 1992-10-26 1993-10-25 Tilidin-dihydrogenorthophosphat, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
EP9302954 1993-10-25

Publications (3)

Publication Number Publication Date
FI951961A FI951961A (fi) 1995-04-25
FI951961A0 true FI951961A0 (fi) 1995-04-25
FI113642B FI113642B (fi) 2004-05-31

Family

ID=6471354

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951961A FI113642B (fi) 1992-10-26 1995-04-25 Menetelmä tilidiinidivetyortofosfaatin valmistamiseksi

Country Status (24)

Country Link
US (1) US5693669A (fi)
EP (1) EP0665830B1 (fi)
JP (1) JP3266261B2 (fi)
KR (1) KR100310041B1 (fi)
AT (1) ATE150004T1 (fi)
AU (1) AU683229B2 (fi)
BG (1) BG61944B1 (fi)
CA (1) CA2147759C (fi)
CZ (1) CZ285637B6 (fi)
DE (1) DE59305805D1 (fi)
DK (1) DK0665830T3 (fi)
ES (1) ES2098792T3 (fi)
FI (1) FI113642B (fi)
GR (1) GR3023186T3 (fi)
HU (1) HU219344B (fi)
MX (1) MX9306607A (fi)
NO (1) NO306395B1 (fi)
NZ (1) NZ257338A (fi)
PL (2) PL174197B1 (fi)
RO (1) RO112851B1 (fi)
RU (1) RU2123998C1 (fi)
SK (1) SK281041B6 (fi)
UA (1) UA42704C2 (fi)
WO (1) WO1994010129A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0913152B1 (de) * 1997-11-03 2001-12-19 Stada Arzneimittel Ag Stabilisiertes Kombinationsarzneimittel enthaltend Naloxone und ein Opiatanalgetikum
DE69908771T2 (de) * 1998-04-28 2004-04-22 Hexal Ag Tilidin-mesylat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen
ATE261302T1 (de) * 1998-05-28 2004-03-15 Krewel Meuselbach Gmbh Retardiertes schmerzmittel enthaltend tilidin
DE19859636A1 (de) * 1998-12-23 2000-06-29 Hexal Ag Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
DE19915602A1 (de) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
DE29908435U1 (de) * 1999-05-11 1999-08-05 Krewel Meuselbach GmbH, 53783 Eitorf Dosiervorrichtung
ES2265538T3 (es) * 2002-06-28 2007-02-16 Stada Arzneimittel Ag Composicion farmaceutica solida que contiene clorhidrato de tilidina.
DE10233108A1 (de) * 2002-07-20 2004-01-29 Krewel Meuselbach Gmbh Retardiertes Schmerzmittel enthaltend Tilidin und ein Lichtschutzmittel
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
EP2168945A1 (en) 2008-09-26 2010-03-31 Hexal Ag Crystalline forms of Tilidine Mesylate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5978M (fi) * 1965-11-19 1968-04-22
DE1793571B1 (de) * 1965-11-19 1971-12-30 Goedecke Ag 3t-Dimethylamino-4-phenyl-4t-carbaethoxy-delta?-cyclohexen und dessen Hydrochlorid
US4933438A (en) * 1984-02-29 1990-06-12 University Of Florida Brain-specific analogues of centrally acting amines
US4800083A (en) * 1986-10-20 1989-01-24 R. P. Scherer Corporation Sustained release method and product
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level

Also Published As

Publication number Publication date
PL308358A1 (en) 1995-07-24
HU219344B (en) 2001-03-28
NO951532L (no) 1995-04-21
FI113642B (fi) 2004-05-31
FI951961A (fi) 1995-04-25
KR950703518A (ko) 1995-09-20
SK281041B6 (sk) 2000-11-07
KR100310041B1 (ko) 2002-04-24
NO951532D0 (no) 1995-04-21
NZ257338A (en) 1996-03-26
WO1994010129A1 (de) 1994-05-11
EP0665830B1 (de) 1997-03-12
PL174739B1 (pl) 1998-09-30
RU95113437A (ru) 1997-02-20
PL174197B1 (pl) 1998-06-30
DE59305805D1 (de) 1997-04-17
BG61944B1 (bg) 1998-10-30
GR3023186T3 (en) 1997-07-30
US5693669A (en) 1997-12-02
AU5370894A (en) 1994-05-24
RU2123998C1 (ru) 1998-12-27
UA42704C2 (uk) 2001-11-15
MX9306607A (es) 1994-04-29
SK52895A3 (en) 1995-12-06
JP3266261B2 (ja) 2002-03-18
HU9501170D0 (en) 1995-06-28
CZ285637B6 (cs) 1999-10-13
DK0665830T3 (da) 1997-09-01
CA2147759A1 (en) 1994-05-11
CZ105295A3 (en) 1995-10-18
HUT73787A (en) 1996-09-30
ES2098792T3 (es) 1997-05-01
EP0665830A1 (de) 1995-08-09
JPH08502505A (ja) 1996-03-19
BG99565A (bg) 1996-01-31
AU683229B2 (en) 1997-11-06
NO306395B1 (no) 1999-11-01
RO112851B1 (ro) 1998-01-30
ATE150004T1 (de) 1997-03-15
CA2147759C (en) 2004-08-10

Similar Documents

Publication Publication Date Title
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
HUP0002296A2 (hu) Sertralinsók és a sertralin elnyújtott felszabadulását biztosító dózisformák
BG104727A (en) Pharmaceutical composition of topiramate
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
HUP9603237A2 (hu) (R)-(-)-2-{N-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzizotiazol-2-il)-butil]-amino-metil}-kromán kristályos hidrokloridja, eljárás előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
FI951961A0 (fi) Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita
HUP0302068A2 (hu) COX-2 inhibitorok alkalmazása immundeficienciával járó rendellenességek kezelésére vagy megelőzésére és ezeket tartalmazó gyógyszerkészítmények
HUP0402577A2 (hu) Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra
HUP9801414A2 (hu) Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények
DE69525649D1 (de) Lamotrigin haltiges arzneimittel
DE59306211D1 (de) Diphosphonsäuren und deren salze enthaltende arzneimittel
AU6122994A (en) Hiv protease inhibitors and their preparation
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
BR9608392A (pt) Preparação multiparticulada de liberação controlada e forma de dosagem em tablete.
MXPA05006528A (es) Proceso para preparar formulaciones farmaceuticas en combinacion utilizando fluidos supercriticos.
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
NO862198D0 (no) 1,8-broforbundne 4-chinolon-3-karboksylsyrer, fremgangsmaate til deres fremstilling, samt legemiddel som inneholder dem, og deres anvendelse til fremstilling av legemiddel.
AU7331287A (en) Pharmaceutical composition of a quarternary ammonium compund and a metal fluoride
GEP20043377B (en) Pharmaceutical Complex
NO307933B1 (no) Vann-uløselig eller lite vannløselig terapeutisk forbindelse, anvendelse derav samt farmasøytisk blanding inneholdende nevnte forbindelse
DK1231908T3 (da) Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf
HUP0004661A2 (hu) (Polihidroxi-butil)-pirazinszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
MA Patent expired